Pulse: FLT3 Inhibition in Post-Transplant AML: Is the Juice Worth the Squeeze?

November 14, 2024

New medications and new guidelines are constantly being released. Pharmacists need a mechanism to keep up with these new medications and guidelines.

Patients with FLT3-mutated AML are at high risk of relapse. FLT3 inhibitors have helped this population survive to transplant, but the optimal approach to post-transplant maintenance therapy has yet to be established. This presentation will increase pharmacist knowledge of recent developments in the shift toward AML targeted therapy to decrease relapse rates.

Target Audience

Pharmacist

Learning Objectives

1. Describe the significance of FLT3 mutations and evolution of targeted treatment in Acute Myeloid Leukemia (AML).
2. Identify dosing regimens and common toxicities of FLT3 inhibitors across all phases of AML.
3. Discuss emerging evidence and implications of FLT3 inhibitor maintenance therapy following hematopoietic cell transplantation.

Additional Information

AttachmentSize
PDF icon Disclosure Slides_Martinez.pdf278.42 KB
Course summary
Available credit: 
  • 1.00 ACPE Pharmacy
    The UPMC Center for Continuing Education in the Health Sciences is accredited by the Accreditation Council for Pharmacy Education (ACPE) as a Provider of continuing pharmacy education.
Course opens: 
11/14/2024
Course expires: 
12/14/2024
Event starts: 
11/14/2024 - 12:00pm EST
Event ends: 
11/14/2024 - 1:00pm EST

New medications and new guidelines are constantly being released. Pharmacists need a mechanism to keep up with these new medications and guidelines.

Patients with FLT3-mutated AML are at high risk of relapse. FLT3 inhibitors have helped this population survive to transplant, but the optimal approach to post-transplant maintenance therapy has yet to be established. This presentation will increase pharmacist knowledge of recent developments in the shift toward AML targeted therapy to decrease relapse rates.

UPMC Presbyterian/ Mercy
Pittsburgh, PA
United States

Mario Martinez, PharmD

 

In support of improving patient care, the University of Pittsburgh is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

 

Pharmacy (CPE)

This knowledge-based activity provides 1.0 contact hours of continuing pharmacy education credit.

 

Available Credit

  • 1.00 ACPE Pharmacy
    The UPMC Center for Continuing Education in the Health Sciences is accredited by the Accreditation Council for Pharmacy Education (ACPE) as a Provider of continuing pharmacy education.
Please login or register to take this course.